Next-generation sequencing identifies potential novel therapeutic targets in Chinese HGSOC patients.

Tao, Junyan; Sun, Dantong; Zhou, Hai; Zhu, Jingjuan; Zhang, Xiaochun; Hou, Helei

Tao, Junyan; Sun, Dantong; Zhou, Hai; Zhu, Jingjuan; Zhang, Xiaochun; Hou, Helei.

Afiliación

Tao J; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, 59 Haier Road, Shandong 266000, China.
Sun D; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, 59 Haier Road, Shandong 266000, China.
Zhou H; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, 59 Haier Road, Shandong 266000, China.
Zhu J; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, 59 Haier Road, Shandong 266000, China.
Zhang X; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, 59 Haier Road, Shandong 266000, China.
Hou H; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266000, 59 Haier Road, Shandong 266000, China. Electronic address: houheleihhl@163.com.

Pathol Res Pract ; 238: 154074, 2022 Oct.

Article en En | MEDLINE | ID: mdl-35988354

Palabras clave

HGSOC; Molecularly targeted therapy; Next-generation sequencing; Personalized therapy; Precision medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pathol Res Pract Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google